247chrislange, Author for 24/7 Tempo

Why This FDA Approval for Pneumonia Treatment Is So Huge

Published: by

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review.

To top